A polyreactive murine monoclonal antibody recognizes numerous polypeptides of Borrelia burgdorferi (1) . One polypeptide recognized by this antibody has an apparent M r of 38.5 and an amino-terminal sequence with strong identity to prokaryotic glyceraldehyde 3-phosphate dehydrogenase (GAPDH). Recent studies with other bacteria have shown that this enzyme or at least a closely related molecule is located on the bacterial surface and can bind to numerous eukaryotic proteins (31) and plasmin(ogen) (6-8, 27, 28) . The presence of a putative GAPDH analog in B. burgdorferi suggested that these organisms also may bind plasminogen.
B. burgdorferi enters the host at the site of a tick bite. The delayed transmission of this organism relative to the formation of a tick-feeding cavity in the dermis (33, 36, 42) ensures that the organism will make initial contact with the host within a hemorrhagic necrotic area. The cellular injury caused by the tick bite leads to inflammatory changes which in turn could lead to the release of plasminogen activators. From its point of entry in the skin, B. burgdorferi can disseminate through the skin itself (33, 36) or invade distant organs after a period of spirochetemia (19, 20) by crossing the endothelium (12, 37) . Movement of spirochetes through the skin or through the basement membrane of endothelium is likely to require the elaboration of proteases to assist in the degradation of extracellular matrices.
We have been unable to detect proteases or proteolytic activity in intact or sonicated B. burgdorferi (unpublished observations). Incorporation of host proteases onto the surface of this organism could supplement or replace the proteolytic activity which seems to be lacking in B. burgdorferi, thereby enhancing tissue invasion. This type of protease incorporation is used effectively by tumor cells (5) and bacteria (4, 6-8, 14, 24, 25, 27-32, 38-41) . In the case of B. burgdorferi, the initial deposition of the organism in an area of inflamed skin and the existence of a potential receptor (GAPDH) for plasmin(ogen), as in Streptococcus spp. (6-8, 27, 28) , led us to test the hypothesis that B. burgdorferi incorporates plasminogen. In the presence of plasminogen activators, active plasmin generated on the surface of the organisms could promote invasiveness. In this study, we show that B. burgdorferi can incorporate plasminogen onto its surface where exogenous urokinase-type plasminogen activator can generate plasmin resulting in greater invasion of endothelial cell monolayers grown on connective tissue substrates.
MATERIALS AND METHODS

Spirochetes. B. burgdorferi B31(9), EvB
Ϫ (11), TI1, TI1Ev, HSK1, HSK1Ev, B31-49, and BEP4 (10) were grown at 33ЊC in a serum-free medium that has been described previously (3) . B313 (35) and Borrelia hermsii (gifts of Alan G. Barbour, San Antonio, Tex.) were grown at 33ЊC in BSK II medium (35) .
Radioiodination of plasminogen. Plasminogen from human plasma was purchased from Sigma, St. Louis, Mo. In sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) (7.5% polyacrylamide) the Sigma plasminogen from human plasma migrated as a single band with an M r of approximately 85,000. NH 2 -terminal amino acid sequence analysis (10) revealed it to be in the Lys form. Radioiodination was done by the Iodo-bead method (Pierce, Rockford, Ill.). Briefly, two Iodo-beads were washed and suspended in 90 l of 0.1 M Na 2 HPO 4 (pH 6.5) in a 1.5-ml microcentrifuge tube. One mCi of 125 I-Na (Du Pont NEN, Boston, Mass.) was added, and the mixture was allowed to incubate for 5 min at 25ЊC. Plasminogen (100 g in 100 l) was then added, and the reaction was allowed to proceed for an additional 5 min at 25ЊC. The mixture was applied to the drained bed of a Sephadex G-25 column (Pharmacia PD-10, Pharmacia Biotech, Inc., Piscataway, N.J.) that had been equilibrated with phosphate-buffered saline (PBS). The column was washed with 1 ml of PBS-1% bovine serum albumin (BSA) followed by 40 ml of PBS. Fractions (0.5 ml) were collected and counted for 1 min in a gamma counter. Peak fractions were pooled and concentrated by using Centricon 30 Microconcentrators (Amicon Division, W. R. Grace & Co., Beverly, Mass.). Percent incorporation was measured by trichloroacetic acid precipitation. The integrity of the labeled plasminogen was verified by SDS-PAGE and autoradiography. The specific activity of the 125 Iplasminogen was approximately 1.8 Ci/g. SDS-PAGE and affinity blotting. In preparation for SDS-PAGE, spirochetes (50 ml of culture) were harvested from the medium by centrifugation, washed twice in PBS, resuspended in 0.5 ml of PBS, and sonicated on ice for 5 min.
Whole-cell lysates (20 g of protein per lane) from various spirochete strains were separated on 10% polyacrylamide gels by reducing SDS-PAGE, using a Laemmli buffer system as adapted for B. burgdorferi (10, 11) . Molecular weight standards that were prestained with Coomassie brilliant blue were purchased from GIBCO BRL, Gaithersburg, Md., and consisted of lysozyme, 15,400; ␤-lactoglobulin, 18,100; carbonic anhydrase, 28,300; ovalbumin, 43,300; bovine serum albumin, 69,800; phosphorylase b, 105,100; and myosin (H-chain), 215,500. Resolved proteins were transferred to an Immobilon-P Transfer Membrane (Millipore Corp., Bedford, Mass.) as previously described (10, 11) , blocked for 2 h with PBS-2.0% BSA, and incubated at 25ЊC for 3 h with 3 ϫ 10 8 cpm of 125 I-plasminogen in PBS-2.0% BSA (pH 7.5) per gel lane. Recombinant OspA and OspB (15) (gifts of John Dunn of Brookhaven National Laboratory), in a range of concentrations from 0.1 to 2.0 g per lane, were subjected to the same procedures. Following incubation, the membrane was washed five times (10 min for each wash) with PBS-2.0% BSA and air dried. Binding of radiolabeled plasminogen was visualized by autoradiography using Kodak X-OMAT-AR imaging film, Eastman Kodak Co., Rochester, N.Y. For competition experiments using ε-aminocaproic acid (EACA), the binding step was done with a range of EACA concentrations (0.1 through 100 mM) in PBS-2.0% BSA. I-plasminogen was determined as the difference between total and nonspecifically bound counts per minute. The resultant data was subjected to binding analysis using the nonlinear data analysis program EnzFitter (Elsevier-Biosoft). In some experiments, both B31 and B313 were used.
Indirect immunofluorescence. Spirochetes (from 10 ml of culture) were harvested by centrifugation and resuspended in 1 ml of PBS. Serial dilutions in PBS of the initial suspension (from 1:2 to 1:128) were applied to microscope slides with precut wells (5 l per well) (Cel-Line Associates, Inc., Newfield, N.J.). The wells were then overlaid with 20 l of plasminogen (1 g per well) in PBS and incubated for 1 h at 33ЊC. Control wells received PBS alone. The slides were washed in PBS, rabbit anti-human plasminogen polyclonal antibody (150 g/ml in PBS-0.5% Tween 20; 20 l per well) (Boehringer Mannheim Corp., Indianapolis, Ind.) was applied, and the slides were incubated for 1 h at 33ЊC. Following a wash step, the slides were incubated for 1 h at 33ЊC with goat anti-rabbit immunoglobulin G (IgG) conjugated to fluorescein isothiocyanate (FITC) (Organon Teknika, Durham, N.C.), washed, and mounted with PBS-30% glycerol. The slides were examined by confocal epifluorescence microscopy.
Chromogenic assay. Chromogenic plasmin substrate S2251 (H-D-Val-LeuLys-pNA-2 HCl) was purchased from Pharmacia Hepar/Chromogenix, Franklin, Ohio. Human urokinase-type plasminogen activator (high molecular weight, two-chain preparation) was purchased from American Diagnostica, Inc., Greenwich, Conn. Spirochetes were harvested by centrifugation and resuspended to a density of 10 8 /ml in PBS-1% BSA, pH 7.5. Aliquots of 1 ml (10 8 spirochetes) in microcentrifuge tubes each received 100 g (in 20 l) of plasminogen. The tubes were incubated for 3 h at 33ЊC with constant gentle end-over-end rotation. The spirochetes were washed three times with PBS-1% BSA, resuspended in 100 l of PBS-1% BSA containing 1.3 IU of human urokinase-type plasminogen activator (u-PA), transferred to 96-well assay plates (Becton Dickinson Labware, Franklin Lakes, N.J.), and incubated for 2 h at 33ЊC. Each well then received 100 l of chromogenic substrate S2251 (250 g/ml final concentration) in 25 mM Tris, pH 8.1. Control groups without B. burgdorferi consisted of PBS-1% BSA alone (followed by u-PA), and a sham preparation to control for possible residual unbound plasminogen not subsequently removed by washing (this group received plasminogen in PBS-1% BSA at the same concentration as used in tubes with B. burgdorferi, followed by u-PA). Control groups with B. burgdorferi consisted of plasminogen alone (no u-PA) and u-PA alone (no previous plasminogen incubation) at the same concentrations as in the experimental group. All groups received the chromogenic substrate S2251 and were subjected to the same manipulations. Each experimental group was performed in triplicate. Plasmin activity was assessed by color development due to enzymatic degradation of the chromogenic substrate (measured at 410 nm in a Dynatech MR 700 microplate reader; Dynatech, Chantilly, Va.) after 2 h of incubation at 37ЊC. Reagent activity was verified before each experiment by measuring the effect of u-PAtreated plasminogen on degradation of S2251.
Preparation of human amniotic membrane. Amniotic membrane was prepared from human placentas obtained shortly after delivery. Briefly, amnion was gently separated from the chorion. Teflon rings were fastened to the exposed surface with Viton O-rings. The epithelium was lysed with 0.25 N NH 4 OH, and debris was scraped away to leave an acellular matrix upon which endothelial cells were cultured. Rings were washed extensively and stored at 4ЊC in HEPES (N-2-hydroxyethylpiperazine-NЈ-2-ethanesulfonic acid)-buffered saline. Before seeding endothelial cells, rings were equilibrated with HUVEC growth medium (see below) for 2 h at 37ЊC.
Endothelial cell-amnion culture. Human umbilical vein endothelial cells (HU-VEC) were isolated by a modification (21) of the method of Jaffe et al. (22) . Briefly, umbilical cords were perfused with a solution of 0.035% collagenase and incubated at 37ЊC for 12 min. Endothelial cells were flushed from the cord and plated onto 1.5% gelatin-coated (16) 60-mm plastic tissue culture plates (Corning Glass Works, Corning, N.Y.). HUVEC were maintained in a growth medium consisting of Medium 199 (M199) (Gibco Laboratories, Grand Island, N.Y.) containing 20% fetal bovine serum (HyClone Laboratories, Logan, Utah), 100 U of penicillin per ml, 100 g of streptomycin per ml, and 2 g of amphotericin B per ml at 37ЊC in a humidified atmosphere of 5% CO 2 -air. After 3 to 5 days, cells from different confluent cultures were trypsinized, pooled, and dispensed onto amnion at a density of 1.5 ϫ 10 5 cells per cm 2 . Within 7 to 10 days, endothelial cells formed a confluent monolayer characterized by intercellular junctions and a transendothelial electrical resistance (21) .
HUVEC-amnion penetration assay. A total of 1.2 ϫ 10 9 B. burgdorferi cells were harvested from serum-free BSK medium by centrifugation and resuspended in 3 ml of fresh binding medium (serum-free BSK medium without gelatin). Then, 1 ml of the spirochete suspension was aliquoted into each of three 1-ml sterile polypropylene cryotubes (Sarstedt, Newton, N.C.) (4 ϫ 10 8 organisms per tube). Two of the tubes received 100 g (20 l) each of plasminogen, while the other received 20 l of PBS. The suspensions were incubated with gentle endover-end rotation at 33ЊC for 3 h. Following incubation, the spirochetes were washed twice with binding medium in a microcentrifuge. One tube containing spirochetes incubated with plasminogen received 1 ml of binding medium supplemented with 5.2 IU of human u-PA. The other tube containing spirochetes incubated with plasminogen and the control tube received 1 ml of binding medium alone and both tubes were incubated overnight at 33ЊC. The spirochetes were then washed twice with binding medium and resuspended in 2 ml of M199 containing 1% BSA for dispensing onto HUVEC monolayers (see below). Prior to addition of treated spirochetes, HUVEC-amnion cultures were rinsed twice with M199-1% BSA in order to remove antibiotics and potential endogenous protease inhibitors. For some experiments, spirochete suspensions which had received plasminogen and u-PA were resuspended in 1 ml of M199-1% BSA with ␣-2 antiplasmin from human plasma (Calbiochem-Novabiochem, La Jolla, Calif.) (70 g/ml) or aprotinin (Sigma) (100 kallikrein inhibitory units [KIU]/ml). For these experiments, all samples were incubated for 15 min at 37ЊC before being added to endothelium. The HUVEC-amnion cultures were rinsed twice with M199-1% BSA and then equilibrated with M199-1% BSA containing ␣ 2 -antiplasmin (70 g/ml) or aprotinin (100 KIU/ml) for 1 h at 37ЊC before addition of spirochetes.
B. burgdorferi suspensions were placed on the HUVEC monolayers (10 8 per ring; four rings per group) and allowed to incubate for 1 h at 37ЊC. HUVEC monolayers were rinsed three times with M199 medium and fixed with 10% formalin for 1 h at 25ЊC. Fixed tissues were immersed in a large volume of PBS with continuous mixing by a magnetic stirbar for 1 h at 4ЊC (procedure used for all subsequent washing steps). Tissues were incubated with hybridoma supernatant containing monoclonal antibody 11G1 (2), which is specific for B. burgdorferi OspA, an abundant outer surface lipoprotein, for 1 h at 37ЊC. After washing, tissues were incubated with FITC-conjugated goat anti-mouse IgM (Kirkegaard and Perry Labs., Inc., Gaithersburg, Md.) for 2 h at 37ЊC. Tissues were washed and cut from Teflon rings with a cork borer. Slides were prepared for fluorescence microscopy by mounting tissues in a mixture of 90% glycerol-10% PBS containing 1,4-phenylenediamine (1 mg/ml) (Aldrich, Milwaukee, Wis.) which allows for demarcation of the endothelial monolayer.
The total number of spirochetes associated with the HUVEC-amnion cultures was determined in six random 400ϫ fields (both migrated and those associated with the apical surface of the endothelium). In order to calculate the percentage of spirochetes migrated, the disposition of spirochetes (above versus below the monolayer) was determined by focusing on the uppermost fibers of the tissue under phase-contrast microscopy. After switching to epifluorescence microscopy, spirochetes found below the endothelium (in the connective tissue) were enumerated. The number of organisms having traversed the endothelial monolayer was presented as a percentage of the total number of spirochetes associated per 400ϫ field. Experimental groups consisted of four replicate HUVEC-amnion cultures. By using the InStat 2.01 Statistical Software Package, the raw data of experimental groups were subjected to an unpaired analysis of variance using the Tukey-Kramer Multiple Comparisons Test, where P Ͻ 0.05 was used as the alpha value to determine statistical significance.
RESULTS
Multiple polypeptides of B. burgdorferi and B. hermsii bind 125 I-plasminogen in affinity blots. A number of B. burgdorferi strains and Borrelia hermsii were tested for their ability to bind 125 I-plasminogen by affinity blotting. High-passage B31 (9), cultured continuously in our laboratory since 1982, low-passage (Ͻ12 passages) tick isolates TI1 (10) and BEP4 (10) , and BEP4, as well as B. hermsii whole-cell lysates, were separated by SDS-PAGE (12.5% polyacrylamide) and transferred to Immobilon-P as described for Fig. 1 . To demonstrate the specificity of plasminogen-spirochete binding, the 125 I-plasminogen probe was incubated with the spirochete whole-cell lysates in the presence of the lysine analog EACA. Figure 2 shows that affinity blotting in the presence of EACA resulted in complete inhibition of (Fig. 3B) . The existence of a low-affinity binding site with a lower K d of 20 Ϯ 4 nM and 2,683 Ϯ 36 binding sites per organism was also suggested by the nonlinear data analysis program (Fig. 3B) . We cannot exclude the possibilities that this low-affinity binding site may be due to breakdown of organisms during the washing steps with resulting binding to internal molecules or that there may be minor Glu-plasminogen contamination in our preparation. In separate experiments, there were no significant differences in the binding of 125 I-plasminogen to B31 and its Osp Ϫ mutant (B313) whole cells (not shown).
Binding of plasminogen to intact B. burgdorferi is punctate by indirect immunofluorescence. Spirochetes (low-passage BEP4 strain) were incubated sequentially with human plasminogen, rabbit anti-human plasminogen and goat anti-rabbit FITC-conjugated antibody. Epifluorescence microscopy revealed that B. burgdorferi bound plasminogen to its outer surface in a well-distributed but punctate manner (Fig. 4) . Controls which did not receive plasminogen were negative (not shown).
Exogenously provided u-PA converts bound plasminogen to enzymatically active plasmin. To determine whether plasminogen bound to the outer surface of B. burgdorferi could be converted to its enzymatically active form, plasmin, either endogenously or by exogenously supplied plasminogen activator, we incubated B. burgdorferi strain BEP4 initially with plasminogen. This was followed by a further incubation with human u-PA and chromogenic plasmin substrate S2251. Degradation of the chromogenic substrate illustrates that plasminogen bound to the surface of B. burgdorferi is converted to enzymatically active plasmin in the presence of exogenous u-PA (P Ͻ 0.01, alternate Welch t test) ( Table 1) . Spirochetes treated with plasminogen alone (without subsequent activation with u-PA) showed only slight degradation of S2251. This experiment was repeated three times with consistent results.
Plasmin-coated B. burgdorferi penetrate HUVEC monolayers to a greater extent than untreated controls. To demonstrate the functional relevance of plasmin bound to the spirochete surface, we employed a HUVEC-amnion penetration assay. Plasmin on the surface of B. burgdorferi was found to significantly enhance their penetration of the HUVEC monolayer and underlying connective tissue in contrast to untreated spirochetes and spirochetes treated with plasminogen but not u-PA (P Ͻ 0.001) (Fig. 5 and 6 ). In addition to migrating organisms, the total number of spirochetes per field (including both migrated organisms and those adherent to the apical surface of the endothelium) was determined by epifluorescence microscopy in six random 400ϫ fields. The results of these determinations indicated there were no statistically significant differences among the groups (not shown).
Treatment of plasmin-coated spirochetes with ␣ 2 -antiplasmin did not significantly inhibit their ability to penetrate the HUVEC monolayer (Fig. 7) . In contrast, treatment with the low-molecular-weight inhibitor aprotinin reduced the spirochetes' ability to penetrate the monolayer to a level not significantly different from that of the untreated control. Again, treatment with either inhibitor did not significantly alter adhesion of B. burgdorferi to the HUVEC (not shown).
DISCUSSION
In this study we have demonstrated that B. burgdorferi can incorporate plasminogen onto its outer surface. The bound plasminogen can, in turn, be converted to enzymatically active plasmin in the presence of exogenous human u-PA. Plasminogen, a normal constituent of plasma, is a single-chain glycoprotein having a molecular weight of approximately 92,000 and a glutamic acid residue at its amino terminus (Glu-plasminogen). It is readily processed to a modified form containing a lysine residue at its amino terminus (Lys-plasminogen). Plas- b This group contained plasminogen and urokinase and was subjected to the same washing procedures as those in groups containing B. burgdorferi to control for possible residual, unbound plasmin effects.
c P Ͻ 0.001 against group I and P Ͻ 0.01 against group II by the alternate Welch t test.
minogen occupies an important niche in the complex equilibrium of hemostasis as the key fibrinolytic mediator. The inactive proenzyme, once bound via its lysine-binding sites to the fibrin molecule, is converted to its two-chain active form, plasmin, as a result of cleavage of the Arg-560-Val-561 bond by plasminogen activators such as u-PA and tissue-type plasminogen activator. Streptokinase, another activator, forms a 1:1 stoichiometric complex with human plasminogen. Plasmin is an aggressive serine protease which, in addition to its main function as the lytic agent of fibrin clots, can also digest other proteins, including laminin, a component of the basement membrane (26) . The latter activity allows tumor cells with bound plasmin(ogen) to metastasize and invade tissues (5) . In addition, both gram-positive and gram-negative bacterial species such as Streptococcus spp. (4, 6-8, 14, 24, 28, 30, 31, 39) , Staphylococcus spp. (25), Haemophilus spp., Branhamella spp., Proteus spp., Pseudomonas spp. (38) , Neisseria spp. (40), and Escherichia coli (32) have been found to bind plasmin(ogen). The existence of a potential receptor for plasminogen in Borrelia spp. (1) as in Streptococcus spp. (4, 6-8, 23, 27, 28) led us to examine the possibility that B. burgdorferi could incorporate plasminogen. While this manuscript was in review, another study demonstrated the binding capacity of plasminogen for B. burgdorferi (18) . Their results are concordant with those presented in this study. Thus, we extend their findings regarding the acquisition of host-derived proteolytic activity. We further show that surface-bound plasmin can lead to increased invasiveness in vitro.
The conditions of the affinity blot experiments using spirochete whole-cell lysates do not simulate how plasminogen Binding analysis and competition studies with EACA show that the interaction of plasminogen with live, intact spirochetes is of both high affinity and specificity. The whole-cell (B. burgdorferi) binding assay using 125 I-plasminogen disclosed the presence of a high-affinity binding site and the possible presence of another, low-affinity binding site (Fig. 3) . Bacterial cells can bind both Glu-and Lys-plasminogen. However, the conformational change that occurs when Glu-plasminogen is processed to the Lys form results in a higher affinity for the bacterial surface (24, 25) . Although Lys-plasminogen was used for the binding assays, a minor Glu-plasminogen contamination could give the appearance of a low-affinity receptor.
The identity of the outer membrane antigen serving as the high-affinity ligand in B. burgdorferi is not known. Such a highaffinity binding site may be one of the antigens capable of binding plasminogen by affinity blot (Fig. 1) . In this regard, an antigen at approximately 20 to 22-kDa seems to bind the radiolabeled plasminogen, at least qualitatively more heavily than the others (Fig. 1) .
Plasmin bound to the surface of B. burgdorferi is enzymatically active as measured by the breakdown of the chromogenic plasmin substrate S2251 (17) . This finding is similar to that reported for Streptococcus spp. (24, 41) and Neisseria spp. (40) . We have also demonstrated that plasmin-coated B. burgdorferi can penetrate an endothelial cell monolayer to a significantly greater extent than untreated control spirochetes or spirochetes coated with unactivated plasminogen (Fig. 5 and 6 ). The greater penetration of plasmin-coated organisms was not due to increased adhesion to the monolayer, as the mean total numbers of spirochetes (migrated organisms and those bound to the apical surface of the endothelium) in untreated control, plasminogen, and plasminogen plus u-PA groups were similar (P Ͼ 0.05). Treatment of plasmin-coated spirochetes with ␣ 2 -antiplasmin did not have a significant inhibitory effect on their invasiveness, while treatment with aprotinin did. Our findings are supported by previous work with group A streptococci (8, 27) , showing that once bound to the bacterial surface, plasmin retains its enzymatic activity and is protected from inhibition by physiological regulators such as ␣ 2 -antiplasmin, as the lysine binding sites used for cell adhesion are also required for ␣ 2 -antiplasmin binding (13, 43) . As in our study, aprotinin has been shown not to discriminate between bound and soluble plasmin (13) .
B. burgdorferi enters the host at a site of local inflammation in the skin produced by the effects of the tick bite (33, 36, 42) . Plasminogen could be bound shortly after entry of the organisms into the skin and subsequently converted to plasmin by activators released in the inflammatory skin focus. Unlike other bacteria with their potent protease arsenals, and notably streptococci, which produce their own fibrinolytic enzymes (i.e., streptokinase), B. burgdorferi does not appear to have endogenous proteases. Hence, acquisition of enzymatically active host proteases may be critical for invasion of the tissues by this organism. While binding of plasmin(ogen) now appears to be a widespread phenomenon among diverse groups of bacteria (30) , this pathway may be of unique importance to Borrelia spp. Crossing of the vasculature is a required invasive step for a systemic organism. The interactions of B. burgdorferi with endothelium have been studied intensively in vitro (12, 37) , as well as in vivo (19, 20) . Furthermore, perivascular and vascular injury are frequent histopathological findings in Lyme disease. The presence of plasmin on the surface of Borrelia spp. could be associated with the development of these injuries.
